Key Points
- Cardlytics CFO David Thomas Evans bought 150,000 shares for $97,500 at $0.65 each, then added another 50,000 shares at $0.63 shortly after, increasing his ownership by more than 127%.
- The stock was trading around $0.60 and has fallen near its 52-week low of $0.57, with a market value of about $34.3 million.
- Cardlytics recently reported a quarterly loss of $0.15 per share, missing estimates, while analysts currently rate the stock Sell on average with a $1.00 price target.
Cardlytics, Inc. (NASDAQ:CDLX - Get Free Report) CFO David Thomas Evans purchased 50,000 shares of the company's stock in a transaction dated Monday, May 18th. The shares were acquired at an average price of $0.63 per share, for a total transaction of $31,500.00. Following the purchase, the chief financial officer directly owned 317,930 shares of the company's stock, valued at approximately $200,295.90. The trade was a 18.66% increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.
David Thomas Evans also recently made the following trade(s):
- On Friday, May 15th, David Thomas Evans acquired 150,000 shares of Cardlytics stock. The stock was bought at an average cost of $0.65 per share, with a total value of $97,500.00.
Cardlytics Stock Down 1.6%
CDLX stock opened at $0.60 on Wednesday. The firm has a 50 day moving average of $0.87 and a 200 day moving average of $1.05. The stock has a market capitalization of $34.34 million, a PE ratio of -0.34 and a beta of 0.67. Cardlytics, Inc. has a 52 week low of $0.57 and a 52 week high of $3.28.
Cardlytics (NASDAQ:CDLX - Get Free Report) last posted its quarterly earnings data on Wednesday, March 4th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of ($0.07) by ($0.08). The company had revenue of $56.10 million for the quarter, compared to analyst estimates of $54.46 million. Cardlytics had a negative return on equity of 956.56% and a negative net margin of 46.03%. On average, equities research analysts expect that Cardlytics, Inc. will post -0.11 earnings per share for the current year.
Institutional Investors Weigh In On Cardlytics
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Quinn Opportunity Partners LLC lifted its holdings in shares of Cardlytics by 900.0% in the 3rd quarter. Quinn Opportunity Partners LLC now owns 1,100,000 shares of the company's stock valued at $2,673,000 after buying an additional 990,000 shares during the period. Vanguard Personalized Indexing Management LLC acquired a new stake in Cardlytics during the third quarter worth about $26,000. Thompson Davis & CO. Inc. acquired a new stake in Cardlytics during the third quarter worth about $111,000. Two Sigma Investments LP raised its position in Cardlytics by 44.7% during the third quarter. Two Sigma Investments LP now owns 125,938 shares of the company's stock valued at $306,000 after acquiring an additional 38,900 shares in the last quarter. Finally, Private Advisor Group LLC purchased a new position in Cardlytics during the third quarter valued at approximately $272,000. 68.10% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
CDLX has been the topic of several research analyst reports. Evercore set a $1.00 price target on Cardlytics in a research note on Friday, March 6th. Wall Street Zen upgraded Cardlytics from a "sell" rating to a "hold" rating in a research note on Saturday, April 4th. Lake Street Capital set a $1.00 target price on Cardlytics in a research report on Friday, May 8th. Weiss Ratings reiterated a "sell (e+)" rating on shares of Cardlytics in a research report on Friday, April 10th. Finally, Bank of America reissued an "underperform" rating on shares of Cardlytics in a research report on Thursday, March 5th. One research analyst has rated the stock with a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the stock currently has an average rating of "Sell" and a consensus target price of $1.00.
View Our Latest Stock Analysis on Cardlytics
Cardlytics Company Profile
(
Get Free Report)
Cardlytics, Inc operates a purchase intelligence and marketing platform that connects advertisers with consumers through bank and credit card transaction data. The company partners with financial institutions to analyze anonymized purchase information, enabling brands to deliver highly targeted offers and rewards directly to customers' online and mobile banking channels. By leveraging real-time insights into consumer spending habits, Cardlytics helps marketers optimize campaign performance and measure return on ad spend more accurately than traditional digital advertising methods.
At the core of Cardlytics' offering is its proprietary purchase intelligence engine, which aggregates and anonymizes transaction data from partner banks and credit unions.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
